SHG · Clinical Research Centre/Lung Cancer CDR (Pilot)
CR
Pilot environment — synthetic demographics; real de-identified pathology sample (n=62; +80 synthetic; total 142).
All patients
Patient Record · MRN SMC-329227

SYN-049

[SYN] Tango Nova · 64y · Male · Indian · BMI 28.4 · ECOG 0
SMCAS - Sunway Medical Centre AS · Medical Oncology · Dr. Lim Hui Yi
IIIA (T2a, N2)Partial Response
Not tested
Clinical storyline

[SYN] Tango Nova, a 64-year-old Indian male (never, ECOG 0), presented in 2023-02 with unintentional weight loss (~5kg over 3 months). Workup confirmed Adenocarcinoma (Stage III). The MDT recommended platinum-based chemo-immunotherapy. Current status: Partial Response.

HPE Results
Adenocarcinoma: Solid, NTRK rearranged
Clinical Stage
IIIA (T2a, N2)
Pathological Stage
IIIA (T2a, N2, Mx)
Adenocarcinoma Subtype
Solid
CEA (ng/mL)
24.2
Tumor (CT/PET)
6.5 cm
PET SUV
9.07
NGS Results
NTRK1 fusion positive